{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "American Society of Clinical Oncology releases so-called value framework to help doctors and patients assess different cancer treatments according to rubric that includes cost as well as efficacy and possibility of side effects; release is part of shift among doctors to address rapid increases in prices of cancer drugs, and value framework takes into account out-of-pocket costs paid by patients and costs to health system.", "type_of_material": "News", "word_count": "1141", "lead_paragraph": "Alarmed by soaring prices for cancer drugs, the leading American oncology society has devised a \u201cvalue framework\u201d to evaluate treatments by effectiveness, side effects and cost.", "pub_date": "2015-06-23T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Cancer Doctors Offer Way to Compare Medicines, Including by Cost", "print_headline": "Evaluating Cancer Drugs on Cost, Too"}, "snippet": "Alarmed by soaring prices for cancer drugs, the leading American oncology society has devised a \u201cvalue framework\u201d to evaluate treatments by effectiveness, side effects and cost.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/06/23/business/cancer-doctors-offer-way-to-compare-medicines-including-by-cost.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Cancer", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "American Society of Clinical Oncology", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}], "blog": [], "_id": "558856a538f0d822a0da2aa8", "source": "The New York Times"}